Systemic and airway inflammation and the presence of emphysema in patients with COPD

Respiratory Medicine

Volumn 104, Issue 2, 2010, Pages 275-282

  Papaioannou, Andriana I ^a   Mazioti, Argyro ^b   Kiropoulos, Theodoros ^a   Tsilioni, Irini ^a   Koutsokera, Angela ^a   Tanou, Kalliopi ^a   Nikoulis, Dimitrios J ^a   Georgoulias, Panagiotis ^a   Zakynthinos, Epameinondas ^a   Gourgoulianis, Konstantinos I ^a   Kostikas, Konstantinos ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b GENERAL HOSPITAL OF LARISSA   (Greece)

Author keywords

Biomarkers; Chronic obstructive pulmonary disease; Emphysema; Exhaled breath condensate; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; LEPTIN; OSTEOCALCIN; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY FAT; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; INFLAMMATION; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; OUTPATIENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; COMPLICATION; EXERCISE TOLERANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; EXERCISE TOLERANCE; HUMANS; INFLAMMATION; MALE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 73749084965     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.09.016     Document Type: Article

References (49)

1. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 6 (2007 Sep 15) 532-555
2. Donaldson G.C., Seemungal T.A., Patel I.S., Bhowmik A., Wilkinson T.M., Hurst J.R., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128 4 (2005 Oct) 1995-2004
3. Sin D.D., and Man S.F. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?. Thorax 61 1 (2006 Jan) 1-3
4. Fabbri L.M., and Rabe K.F. From COPD to chronic systemic inflammatory syndrome?. Lancet 370 9589 (2007 Sep 1) 797-799
5. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., and Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 3 (2007 Feb 1) 250-255
6. Hurst J.R., Perera W.R., Wilkinson T.M., Donaldson G.C., and Wedzicha J.A. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173 1 (2006 Jan 1) 71-78
7. Koutsokera A., Kiropoulos T.S., Nikoulis D.J., Daniil Z.D., Tsolaki V., Tanou K., et al. Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respir Med (2009 Jan 2)
8. Rennard S.I. Looking at the patient-approaching the problem of COPD. N Engl J Med 350 10 (2004 Mar 4) 965-966
9. Celli B.R., and Roger S. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and their clinical relevance. Proc Am Thorac Soc 3 6 (2006 Aug) 461-465
10. Wouters E.F. Approaches to improving health status in chronic obstructive pulmonary disease: one or several?. Proc Am Thorac Soc 3 3 (2006 May) 262-269
11. Boschetto P., Quintavalle S., Zeni E., Leprotti S., Potena A., Ballerin L., et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 61 12 (2006 Dec) 1037-1042
12. Horvath I., Hunt J., Barnes P.J., Alving K., Antczak A., Baraldi E., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26 3 (2005 Sep) 523-548
13. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 152 3 (1995 Sep) 1107-1136
14. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Bioelectrical impedance analysis - part I: review of principles and methods. Clin Nutr 23 5 (2004 Oct) 1226-1243
15. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Manuel Gomez J., et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 23 6 (2004 Dec) 1430-1453
16. VanItallie T.B., Yang M.U., Heymsfield S.B., Funk R.C., and Boileau R.A. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 52 6 (1990 Dec) 953-959
17. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 1 (2002 Jul 1) 111-117
18. Park K.J., Bergin C.J., and Clausen J.L. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 211 2 (1999 May) 541-547
19. Mahler D.A., and Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest 93 3 (1988 Mar) 580-586
20. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 10 (2004 Mar 4) 1005-1012
21. Jones P.W., Quirk F.H., Baveystock C.M., and Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145 6 (1992 Jun) 1321-1327
22. Katsabeki-Katsafli A., Kerenidi T., Kostikas K., Dalaveris E., Kiropoulos T.S., Gogou E., et al. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 60 2 (2008 May) 271-276
23. Daniil Z.D., Papageorgiou E., Koutsokera A., Kostikas K., Kiropoulos T., Papaioannou A.I., et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 21 1 (2008) 26-31
24. Kostikas K., Papatheodorou G., Ganas K., Psathakis K., Panagou P., and Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 165 10 (2002 May 15) 1364-1370
25. Jones P.W. Health status measurement in chronic obstructive pulmonary disease. Thorax 56 11 (2001 Nov) 880-887
26. Makita H., Nasuhara Y., Nagai K., Ito Y., Hasegawa M., Betsuyaku T., et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 62 11 (2007 Nov) 932-937
27. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 5 Pt 1 (1998 May) 1418-1422
28. van Manen J.G., Bindels P.J., Dekker F.W., Cj I.J., van der Zee J.S., and Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 57 5 (2002 May) 412-416
29. Repine J.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156 2 Pt 1 (1997 Aug) 341-357
30. Kostikas K., Papatheodorou G., Psathakis K., Panagou P., and Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124 4 (2003 Oct) 1373-1380
31. Cesarone M.R., Belcaro G., Carratelli M., Cornelli U., De Sanctis M.T., Incandela L., et al. A simple test to monitor oxidative stress. Int Angiol 18 2 (1999 Jun) 127-130
32. Langen R.C., Korn S.H., and Wouters E.F. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 35 3 (2003 Aug 1) 226-235
33. Agusti A.G., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 2 (2003 Feb) 347-360
34. Sin D.D., Anthonisen N.R., Soriano J.B., and Agusti A.G. Mortality in COPD: role of comorbidities. Eur Respir J 28 6 (2006 Dec) 1245-1257
35. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 11 (2003 Mar 25) 1514-1519
36. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 18 (1998 May 13) 1477-1482
37. Leuchte H.H., Baumgartner R.A., Nounou M.E., Vogeser M., Neurohr C., Trautnitz M., et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 173 7 (2006 Apr 1) 744-750
38. Bozkanat E., Tozkoparan E., Baysan O., Deniz O., Ciftci F., and Yokusoglu M. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J Int Med Res 33 5 (2005 Sep-Oct) 537-544
39. Hopkinson N.S., Tennant R.C., Dayer M.J., Swallow E.B., Hansel T.T., Moxham J., et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8 (2007) 25
40. Ischaki E., Papatheodorou G., Gaki E., Papa I., Koulouris N., and Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132 1 (2007 Jul) 164-169
41. Calikoglu M., Sahin G., Unlu A., Ozturk C., Tamer L., Ercan B., et al. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 71 1 (2004 Jan-Feb) 45-50
42. Tomoda K., Yoshikawa M., Itoh T., Tamaki S., Fukuoka A., Komeda K., et al. Elevated circulating plasma adiponectin in underweight patients with COPD. Chest 132 1 (2007 Jul) 135-140
43. Wouters E.F., Groenewegen K.H., Dentener M.A., and Vernooy J.H. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 4 8 (2007 Dec) 626-634
44. Spruit M.A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., Bogaerts P., et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 58 9 (2003 Sep) 752-756
45. Wagner P.D. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?. Respirology 11 6 (2006 Nov) 681-686
46. Bolton C.E., Ionescu A.A., Shiels K.M., Pettit R.J., Edwards P.H., Stone M.D., et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 12 (2004 Dec 15) 1286-1293
47. Bugel S. Vitamin K and bone health in adult humans. Vitam Horm 78 (2008) 393-416
48. Buyukkaplan U.S., Akkaya A., Yildiz M., Bircan A., Aksoy Dogan A., Ozturk O., et al. Mineral status of COPD patients under long-term inhaled corticosteroid therapy oral corticosteroids for stable chronic obstructive pulmonary disease. J Prosthodont 3 (2008 Jun 20) CD005374
49. Walters J.A., Walters E.H., and Wood-Baker R. Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3 (2005) CD005374